medecolМедицина и экологияMedicine and ecology2305-60452305-6053Карагандинский медицинский университет10.59598/ME-2305-6053-2026-119-2-8-17medecol-1332Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWSХроническая болезнь почек у пациентов пожилого и старческого возраста с коморбидной патологиейChronic kidney disease in elderly and senile patients with comorbid pathologyКузановД. Б.KuzanovD. B.

Данияр Бигалиевич Кузанов

050000, г. Алматы, ул. Толе Би, 94

050000, Almaty с., Tole Bi str., 94

daniar_kuzanov@mail.ruШепетовА. М.ShepetovA. M.

050000, г. Алматы, ул. Толе Би, 94

050000, Almaty с., Tole Bi str., 94

КабулбаевК. А.KabulbayevK. A.

050000, г. Алматы, ул. Толе Би, 94; 050000, г. Алматы, Айтеке Би, 120

050000, Almaty с., Tole Bi str., 94; 050000, Almaty с., Aiteke Bi, 120

БалмухановаА. М.BalmukhanovaA. M.

050040, г. Алматы, пр-т Aль-Фараби, 71

050040, Almaty с., Al-Farabi ave., 71

ЖумабаеваГ. Б.ZhumabayevaG. B.

050040, г. Алматы, пр-т Aль-Фараби, 71; 050022, г. Алматы, пр-т Абая, 85

Daniyar Bigalievich Kuzanov 

050040, Almaty с., Al-Farabi ave., 71; 050022, Almaty с., Abaya ave., 85

 

info@kaznu.edu.kzКафедра нефрологии, НАО «Казахский национальный медицинский университет им. С. Д. Асфендиярова»КазахстанDepartment of Nephrology, NС JSC «Asfendiyarov Kazakh National Medical University»KazakhstanКафедра нефрологии, НАО «Казахский национальный медицинский университет им. С. Д. Асфендиярова»; АО «Научно-исследовательский институт кардиологии и внутренних болезней»КазахстанDepartment of Nephrology, NС JSC «Asfendiyarov Kazakh National Medical University» ; JSC «Scientific Research Institute of Cardiology and Internal Diseases»KazakhstanКафедра политики и организации здравоохранения, НАО «Казахский Национальный университет им. аль-Фараби»КазахстанDepartment of Health Policy and Organization, NС JSC «Al-Farabi Kazakh National University»KazakhstanКафедра политики и организации здравоохранения, НАО «Казахский Национальный университет им. аль-Фараби»; Кафедра анатомии, физиологии и спортивной медицины, Казахская академия спорта и туризмаКазахстанDepartment of Health Policy and Organization, NС JSC «Al-Farabi Kazakh National University» ; Department of Anatomy, Physiology and Sports Medicine, Kazakh Academy of Sports and TourismKazakhstan20261508202602817Copyright © Кузанов Д.Б., Шепетов А.М., Кабулбаев К.А., Балмуханова А.М., Жумабаева Г.Б., 20262026Кузанов Д.Б., Шепетов А.М., Кабулбаев К.А., Балмуханова А.М., Жумабаева Г.Б.Kuzanov D.B., Shepetov A.M., Kabulbayev K.A., Balmukhanova A.M., Zhumabayeva G.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://medecol.qmu.kz/jour/article/view/1332

Обзор посвящен анализу текущих данных по проблемам диагностики и лечения хронической болезни почек у пациентов пожилого и старческого возраста с коморбидной патологией. В работе рассматриваются основные виды коморбидной патологии в совокупности с хронической болезнью почек. На основе анализа современной литературы выделены ключевые направления для дальнейших исследований. Полученные данные подчеркивают важность отдельного подхода к диагностике и лечению данного заболевания у пациентов пожилого и старческого возраста с коморбидной патологией. Проведенный литературный обзор подчеркивает необходимость комплексного подхода к ведению пациентов пожилого и старческого возраста с коморбидной патологией, включая раннюю диагностику, тщательную оценку коморбидных состояний и своевременное начало лечения, направленного на замедление прогрессирования заболевания и улучшение качества жизни. В дальнейшем требуется проведение дополнительных исследований для более глубокого понимания механизмов взаимодействия хронической болезни почек с другими заболеваниями у пожилых пациентов, а также разработки новых подходов к диагностике и лечению. 

This review article is devoted to the analysis of current data on the problems of diagnosis and treatment of chronic kidney disease in elderly and senile patients with comorbid pathologies. The work considers the main comorbid pathologies in combination with chronic kidney disease. Based on the analysis of modern literature, key areas for further research are identified. The data obtained emphasize the importance of a separate approach to the diagnosis and treatment of this disease in elderly and senile patients with comorbid pathology.

The literature review highlights the need for an integrated approach to the management of elderly and senile patients with comorbid pathology, including early diagnosis, careful assessment of comorbid conditions, and timely initiation of treatment aimed at slowing the progression of the disease and improving quality of life. In the future, additional research is required to better understand the mechanisms of interaction of chronic kidney disease with other diseases in elderly patients, as well as to develop new approaches to diagnosis and treatment.

хроническая болезнь почекпожилые пациентыкоморбидная патологиядиагностикалечениекомплексный подходchronic kidney diseaseelderly patientscomorbid pathologydiagnosistreatmentintegrated approachReferencesFerrer A., Formiga F., Henríquez E., Lombarte I., Olmedo C., Pujol R. Evaluación funcional y cognitiva en una población urbana de mayores de 89 años. Estudio NonaSantfeliu. Rev. Esp. Geriatr. Gerontol . 2006; 41: 21-26.Ferrer A., Formiga F., Henríquez E., Lombarte I., Olmedo C., Pujol R. Evaluación funcional y cognitiva en una población urbana de mayores de 89 años. Estudio NonaSantfeliu. Rev. Esp. Geriatr. Gerontol . 2006; 41: 21-26.Kooman J.P., van der Sande F.M., Leunissen K.M. Kidney disease and aging: A reciprocal relation. Exp. Gerontol . 2017; 87: 156-159. https://doi.org/10.1016/j.exger.2016.02.003Kooman J.P., van der Sande F.M., Leunissen K.M. Kidney disease and aging: A reciprocal relation. Exp. Gerontol . 2017; 87: 156-159. https://doi.org/10.1016/j.exger.2016.02.003Stevens L.A., Viswanathan G., Weiner D.E. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future Adv. Chronic projections, and clinical significance. Kidney Dis . 2010; 17 (4): 293-301. https://doi.org/10.1053/j.ackd.2010.03.010.Stevens L.A., Viswanathan G., Weiner D.E. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, Adv. future projections, and clinical significance. Chronic Kidney Dis . 2010; 17 (4): 293-301. https://doi.org/10.1053/j.ackd.2010.03.010.Chow E., Merchant A.A., Molnar F., Frank C. Approach to chronic kidney disease in the elderly. Can. Fam. Physician . 2023; 69 (1): 25-27. https://doi.org/10.46747/cfp.690125Chow E., Merchant A.A., Molnar F., Frank C. Approach to chronic kidney disease in the elderly. Can. Fam. Physician . 2023; 69 (1): 25-27. https://doi.org/10.46747/cfp.690125Roderick P.J., Atkins R.J., Smeeth L., Nitsch D.M., Hubbard R.B., Fletcher A.E., et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing. 2008; 37: 179-186. https://doi.org/10.1093/ageing/afm180Roderick P.J., Atkins R.J., Smeeth L., Nitsch D.M., Hubbard R.B., Fletcher A.E., et al. Detecting chronic kidney disease in older people; what are the implications? Age Ageing. 2008; 37: 179-186. https://doi.org/10.1093/ageing/afm180Lamb E.J., Levey A.S., Stevens P.E. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin. Chem. 2013; 59 (3): 462-465. https://doi.org/10.1373/clinchem.2012.184259Lamb E.J., Levey A.S., Stevens P.E. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: evolution not revolution. Clin. Chem. 2013; 59 (3): 462465. https://doi.org/10.1373/clinchem.2012.184259Jha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y., Yang C.W. Chronic kidney disease: global dimension and perspectives. Lancet . 2013; 382 (9888): 260-272. https://doi.org/10.1016/S0140-6736(13)60687-XJha V., Garcia-Garcia G., Iseki K., Li Z., Naicker S., Plattner B., Saran R., Wang A.Y., Yang C.W. Chronic kidney disease: global dimension and perspectives. Lancet . 2013; 382 (9888): 260-272. https://doi.org/10.1016/S0140-6736(13)60687-XLiyanage T., Ninomiya T., Jha V., Neal B., Patrice H.M., Okpechi I., Zhao M.H., Lv J., Garg A.X., Knight J., Rodgers A., Gallagher M., Kotwal S., Cass A., Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet . 2015; 385 (9981): 1975-1982. https://doi.org/10.1016/S0140-6736(14)61601-9Liyanage T., Ninomiya T., Jha V., Neal B., Patrice H.M., Okpechi I., Zhao M.H., Lv J., Garg A.X., Knight J., Rodgers A., Gallagher M., Kotwal S., Cass A., Perkovic V. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet . 2015; 385 (9981): 1975-1982. https://doi.org/10.1016/S0140-6736(14)61601-9Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 2014; 103 (2): 137-149. https://doi.org/10.1016/j.diabres.2013.11.002Guariguata L., Whiting D.R., Hambleton I., Beagley J., Linnenkamp U., Shaw J.E. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res. Clin. Pract. 2014; 103 (2): 137-149. https://doi.org/10.1016/j.diabres.2013.11.002Nanditha A., Ma R.C., Ramachandran A., Snehalatha C., Chan J.C., Chia K.S., Shaw J.E., Zimmet P.Z. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016; 39 (3): 472-485. https://doi.org/10.2337/dc15-1536. PMID: 26908931Nanditha A., Ma R.C., Ramachandran A., Snehalatha C., Chan J.C., Chia K.S., Shaw J.E., Zimmet P.Z. Diabetes in Asia and the Pacific: Implications for the Global Epidemic. Diabetes Care. 2016; 39 (3): 472-485. https://doi.org/10.2337/dc15-1536. PMID: 26908931Нурсултанова Л. Н. Распространенность хронической болезни почек в Казахстане (обзор литературы). Вестник Казахского Национального медицинского университета. 2020; 4: 291-294.Нурсултанова Л. Н. Распространенность хронической болезни почек в Казахстане (обзор литературы). Вестник Казахского Национального медицинского университета. 2020; 4: 291-294.Webster A.C., Nagler E.V., Morton R.L., Masson P. Chronic Kidney Disease. The Lancet. 2017; 389: 1238-1252. https://doi.org/10.1016/ S0140-6736(16)32064-5Webster A.C., Nagler E.V., Morton R.L., Masson P. Chronic Kidney Disease. The Lancet. 2017; 389: 1238-1252. https://doi.org/10.1016/ S0140-6736(16)32064-5Brosnahan G.M., Abebe K.Z., Moore C.G., et al. Patterns of kidney function decline in autosomal dominant polycystic kidney disease: a post hoc analysis from the HALT-PKD trials. Am. J. Kidney. Dis. 2018; 71: 666-676. https://doi.org/10.1053/j. ajkd.2017.10.023Brosnahan G.M., Abebe K.Z., Moore C.G., et al. Patterns of kidney function decline in autosomal dominant polycystic kidney disease: a post hoc analysis from the HALT-PKD trials. Am. J. Kidney. Dis. 2018; 71: 666-676. https://doi.org/10.1053/j.ajkd.2017.10.023Formiga F., Ferrer A., Cruzado J.M., Padros G., Fanlo M., Roson B., Pujol R. Geriatric assessment and chronic kidney disease in the oldest old: the Octabaix study. Eur. J. Intern. Med. 2012; 23 (6): 534-538. https://doi.org/10.1016/j.ejim.2012.03.009Formiga F., Ferrer A., Cruzado J.M., Padros G., Fanlo M., Roson B., Pujol R. Geriatric assessment and chronic kidney disease in the oldest old: the Octabaix study. Eur. J. Intern. Med. 2012; 23 (6): 534-538. https://doi.org/10.1016/j.ejim.2012.03.009Colombo M.G., Förster C., Wallwiener S., Hassdenteufel K., Hawighorst-Knapstein S., Kirtschig G., Chaudhuri A., Dally S., Joos S. Comorbidity, life-style factors and healthcare utilization in incident chronic kidney disease: sex-specific analyses of claims data. Nephrol. Dial. Transplant. 2023; 38 (3): 722-732. https://doi.org/10.1093/ndt/gfac245Colombo M.G., Förster C., Wallwiener S., Hassdenteufel K., Hawighorst-Knapstein S., Kirtschig G., Chaudhuri A., Dally S., Joos S. Comorbidity, life-style factors and healthcare utilization in incident chronic kidney disease: sex-specific analyses of claims data. Nephrol. Dial. Transplant. 2023; 38 (3): 722-732. https://doi.org/10.1093/ndt/gfac245Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease -A systematic review and meta-analysis. PLoS One 2016; 11: e0158765. https://doi.org/10.1371/journal.pone.0158765Hill N.R., Fatoba S.T., Oke J.L., et al. Global prevalence of chronic kidney disease -A systematic review and meta-analysis. PLoS One 2016; 11: e0158765. https://doi.org/10.1371/journal.pone.0158765Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet . 2013; 382: 339-352. https://doi.org/10.1016/S0140-6736(13)60595-4Gansevoort R.T., Correa-Rotter R., Hemmelgarn B.R., et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet . 2013; 382: 339-352. https://doi.org/10.1016/S0140-6736(13)60595-4Bright R. Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine. Med. Chir. Rev. 1836; 25 (49): 23-35.Bright R. Cases and Observations Illustrative of Renal Disease, Accompanied with the Secretion of Albuminous Urine. Med. Chir. Rev. 1836; 25 (49): 23-35.Jankowski J., Floege J., Fliser D., Böhm M., Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation . 2021; 143 (11): 1157-1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686Jankowski J., Floege J., Fliser D., Böhm M., Marx N. Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options. Circulation . 2021; 143 (11): 1157-1172. https://doi.org/10.1161/CIRCULATIONAHA.120.050686Stevens P.E., O’Donoghue D.J., de Lusignan S., Van Vlymen J., Klebe B., Middleton R., Hague N., New J., Farmer C.K. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007; 72: 92-99. https://doi.org/10.1038/sj.ki.5002273Stevens P.E., O’Donoghue D.J., de Lusignan S., Van Vlymen J., Klebe B., Middleton R., Hague N., New J., Farmer C.K. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int. 2007; 72: 92-99. https://doi.org/10.1038/sj.ki.5002273Thompson S., James M., Wiebe N., Hemmelgarn B., Manns B., Klarenbach S., Tonelli M.; Alberta Kidney Disease Network. Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrol. 2015; 26: 2504-2511. https://doi.org/10.1681/ASN.2014070714Thompson S., James M., Wiebe N., Hemmelgarn B., Manns B., Klarenbach S., Tonelli M.; Alberta Kidney Disease Network. Cause of death in patients with reduced kidney function. J. Am. Soc. Nephrol. 2015; 26: 2504-2511. https://doi.org/10.1681/ASN.2014070714Vanholder R., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P.P., Deppisch R., Descamps-Latscha B., Henle T., et al. Uremic toxicity: present state of the art. Int. J. Artif. Organs. 2001; 24: 695-725. https://doi.org/10.1177/039139880102401004Vanholder R., Argilés A., Baurmeister U., Brunet P., Clark W., Cohen G., De Deyn P.P., Deppisch R., Descamps-Latscha B., Henle T., et al. Uremic toxicity: present state of the art. Int. J. Artif. Organs. 2001; 24: 695-725. https://doi.org/10.1177/039139880102401004Weiner D.E., Tighiouart H., Elsayed E.F., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. The Framingham predictive instrument in chronic kidney disease. J. Am. Coll. Cardiol. 2007; 50: 217-224. https://doi.org/10.1016/j.jacc.2007.03.037Weiner D.E., Tighiouart H., Elsayed E.F., Griffith J.L., Salem D.N., Levey A.S., Sarnak M.J. The Framingham predictive instrument in chronic kidney disease. J. Am. Coll. Cardiol. 2007; 50: 217-224. https://doi.org/10.1016/j.jacc.2007.03.037Roehm B., Weiner D.E. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines. Curr. Opin.Nephrol. Hypertens. 2019; 28: 245-250. https://doi.org/10.1097/MNH. 0000000000000492Roehm B., Weiner D.E. Blood pressure targets and kidney and cardiovascular disease: same data but discordant guidelines. Curr. Opin.Nephrol. Hypertens. 2019; 28: 245-250. https://doi.org/10.1097/MNH.0000000000000492McGonigle R.J., Wallin J.D., Shadduck R.K., Fisher J.W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984; 25 (2): 437-444. https://doi.org/10.1038/ki.1984.36McGonigle R.J., Wallin J.D., Shadduck R.K., Fisher J.W. Erythropoietin deficiency and inhibition of erythropoiesis in renal insufficiency. Kidney Int. 1984; 25 (2): 437-444. https://doi.org/10.1038/ki.1984.36Wouters H.J.C.M., van der Klauw M.M., de Witte T., Stauder R., Swinkels D.W., Wolffenbuttel B.H.R., Huls G. Association of anemia with health-related quality of life and survival: a large population-based cohort study. Haematologica . 2019; 104 (3): 468-476. https://doi.org/10.3324/haematol.2018.195552Wouters H.J.C.M., van der Klauw M.M., de Witte T., Stauder R., Swinkels D.W., Wolffenbuttel B.H.R., Huls G. Association of anemia with health-related quality of life and survival: a large population-based cohort study. Haematologica . 2019; 104 (3): 468-476. https://doi.org/10.3324/haematol.2018.195552Locatelli F., Nissenson A.R., Barrett B.J., Walker R.G., Wheeler D.C., Eckardt K.U., Lameire N.H., Eknoyan G. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008; 74 (10): 1237-1240. https://doi.org/10.1038/ki.2008.299Locatelli F., Nissenson A.R., Barrett B.J., Walker R.G., Wheeler D.C., Eckardt K.U., Lameire N.H., Eknoyan G. Clinical practice guidelines for anemia in chronic kidney disease: problems and solutions. A position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2008; 74 (10): 1237-1240. https://doi.org/10.1038/ki.2008.299Moist L.M., Troyanov S., White C.T., Wazny L.D., Wilson J.A., McFarlane P., Harwood L., Sood M.M., Soroka S.D., Bass A., Manns B.J. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am. J. Kidney Dis. 2013; 62 (5): 860-873. https://doi.org/10.1053/j.ajkd.2013.08.001Moist L.M., Troyanov S., White C.T., Wazny L.D., Wilson J.A., McFarlane P., Harwood L., Sood M.M., Soroka S.D., Bass A., Manns B.J. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD. Am. J. Kidney Dis. 2013; 62 (5): 860-873. https://doi.org/10.1053/j.ajkd.2013.08.001Ravender R., Roumelioti M.E., Schmidt D.W., Unruh M.L., Argyropoulos C. Chronic Kidney Disease in the Older Adult Patient with Diabetes. J. Clin. Med. 2024; 13 (2): 348. https://doi.org/10.3390/jcm13020348Ravender R., Roumelioti M.E., Schmidt D.W., Unruh M.L., Argyropoulos C. Chronic Kidney Disease in the Older Adult Patient with Diabetes. J. Clin. Med. 2024; 13 (2): 348. https://doi.org/10.3390/jcm13020348Watanabe K., Okuro M., Okuno T., Iritani O., Yano H., Himeno T., Morita T., Igarashi Y., Nakahashi T., Morimoto S. Comorbidity of chronic kidney disease, diabetes and lower glycated hemoglobin predicts support/care-need certification in community-dwelling older adults. Geriatr. Gerontol. Int. 2018; 18 (4): 521-529. https://doi.org/10.1111/ggi.13211Watanabe K., Okuro M., Okuno T., Iritani O., Yano H., Himeno T., Morita T., Igarashi Y., Nakahashi T., Morimoto S. Comorbidity of chronic kidney disease, diabetes and lower glycated hemoglobin predicts support/care-need certification in community-dwelling older adults. Geriatr. Gerontol. Int. 2018; 18 (4): 521-529. https://doi.org/10.1111/ggi.13211Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008; 358: 2560-2572. https://doi.org/10.1056/NEJMoa0802987Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., Marre M., Cooper M., Glasziou P., Grobbee D., et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008; 358: 2560-2572. https://doi.org/10.1056/NEJMoa0802987Charles C., Ferris A.H. Chronic Kidney Disease. Prim Care. 2020; 47 (4): 585-595. https://doi.org/10.1016/j.pop.2020.08.001Charles C., Ferris A.H. Chronic Kidney Disease. Prim Care. 2020; 47 (4): 585-595. https://doi.org/10.1016/j.pop.2020.08.001Riddle M.C. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation . 2010; 122: 844-846. https://doi.org/10.1161/CIRCULATIONAHA.110.960138Riddle M.C. Effects of intensive glucose lowering in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation . 2010; 122: 844-846. https://doi.org/10.1161/CIRCULATIONAHA.110.960138Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., Zieve F.J., Marks J., Davis S.N., Hayward R., et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009; 360: 129-139. https://doi.org/10.1056/NEJMoa0808431Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., Zieve F.J., Marks J., Davis S.N., Hayward R., et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 2009; 360: 129-139. https://doi.org/10.1056/ NEJMoa0808431Mallappallil M., Friedman E.A., Delano B.G., McFarlane S.I., Salifu M.O. Chronic kidney disease in the elderly: evaluation and management. Clin. Pract. (Lond). 2014; 11 (5): 525-535. https://doi.org/10.2217/cpr.14.46Mallappallil M., Friedman E.A., Delano B.G., McFarlane S.I., Salifu M.O. Chronic kidney disease in the elderly: evaluation and management. Clin. Pract. (Lond). 2014; 11 (5): 525-535. https://doi.org/10.2217/cpr.14.46Maini R., Wong D.B., Addison D., Chiang E., Weisbord S.D., Jneid H. Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era. J. Am. Soc. Nephrol. 2018; 29: 2782-2786. https://doi.org/10.1681/ASN.2018070674Maini R., Wong D.B., Addison D., Chiang E., Weisbord S.D., Jneid H. Persistent underrepresentation of kidney disease in randomized, controlled trials of cardiovascular disease in the contemporary era. J. Am. Soc. Nephrol. 2018; 29: 2782-2786. https://doi.org/10.1681/ASN.2018070674Zewinger S., Kleber M.E., Rohrer L., Lehmann M., Triem S., Jennings R.T., Petrakis I., Dressel A., Lepper P.M., Scharnagl H., et al. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur. Heart J. 2017; 38: 1597-1607. https://doi.org/10.1093/eurheartj/ehx118Zewinger S., Kleber M.E., Rohrer L., Lehmann M., Triem S., Jennings R.T., Petrakis I., Dressel A., Lepper P.M., Scharnagl H., et al. Symmetric dimethylarginine, high-density lipoproteins and cardiovascular disease. Eur. Heart J. 2017; 38: 1597-1607. https://doi.org/10.1093/eurheartj/ehx118Phoon R.K. Chronic kidney disease in the elderly assessment and management. Aust. Fam. Physician. 2012; 41 (12): 940-944.Phoon R.K. Chronic kidney disease in the elderly assessment and management. Aust. Fam. Physician. 2012; 41 (12): 940-944.Shroff R., Speer T., Colin S., Charakida M., Zewinger S., Staels B., Chinetti-Gbaguidi G., Hettrich I., Rohrer L., O’Neill F., et al. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J. Am. Soc. Nephrol. 2014; 25: 2658-2668. https://doi.org/10.1681/ASN.2013111212Shroff R., Speer T., Colin S., Charakida M., Zewinger S., Staels B., Chinetti-Gbaguidi G., Hettrich I., Rohrer L., O’Neill F., et al. HDL in children with CKD promotes endothelial dysfunction and an abnormal vascular phenotype. J. Am. Soc. Nephrol. 2014; 25: 2658-2668. https://doi.org/10.1681/ASN.2013111212Mikolasevic I., Žutelija M., Mavrinac V., Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int. J. Nephrol. Renovasc. Dis. 2017; 10: 35-45. https://doi.org/10.2147/IJNRD.S101808Mikolasevic I., Žutelija M., Mavrinac V., Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int. J. Nephrol. Renovasc. Dis. 2017; 10: 35-45. https://doi.org/10.2147/IJNRD.S101808Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021; 99 (3S): S1-S87. https://doi.org/10.1016/j.kint.2020.11.003Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021; 99 (3S): S1-S87. https://doi.org/10.1016/j.kint.2020.11.003Kudina E.V., Skvortsov R.A., Larina V.N., Zhuk V.A., Ivanova M.Z. Elderly with chronic kidney disease in outpatient treatment: risk factors and prevention pathways. Russian Journal of Geriatric Medicine . 2021; 1: 53-59. https://doi.org/10.37586/2686-8636-1-2021-53-59Kudina E.V., Skvortsov R.A., Larina V.N., Zhuk V.A., Ivanova M.Z. Elderly with chronic kidney disease in outpatient treatment: risk factors and prevention pathways. Russian Journal of Geriatric Medicine . 2021; 1: 53-59. https://doi.org/10.37586/2686-8636-1-2021-53-59Liang X., Ye M., Tao M., Zheng D., Cai R., Zhu Y., Jin J., He Q. The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study. BMC Nephrol. 2020; 21 (1): 252. https://doi.org/10.1186/s12882-020-01907-5Liang X., Ye M., Tao M., Zheng D., Cai R., Zhu Y., Jin J., He Q. The association between dyslipidemia and the incidence of chronic kidney disease in the general Zhejiang population: a retrospective study. BMC Nephrol. 2020; 21 (1): 252. https://doi.org/10.1186/s12882-020-01907-5Kelly D.M., Anders H.-J., Bello A.K., et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney International Supplements.2021; 11: e106-e118. https://doi.org/10.1016/j. kisu.2021.01.007Kelly D.M., Anders H.-J., Bello A.K., et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney International Supplements. 2021; 11: e106-e118. https://doi.org/10.1016/j.kisu.2021.01.007Saran R., Robinson B., Abbott K.C., et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases. 2019; 73: A7A8. https://doi.org/10.1053/j.ajkd.2019.01.001Saran R., Robinson B., Abbott K.C., et al. US Renal Data System 2018 Annual Data Report: Epidemiology of Kidney Disease in the United States. American Journal of Kidney Diseases. 2019; 73: A7A8. https://doi.org/10.1053/j.ajkd.2019.01.001Thomas M.C., Cooper M.E., Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat. Rev. Nephrol. 2016; 12: 73-81. https://doi.org/10.1038/nrneph.2015.173Thomas M.C., Cooper M.E., Zimmet P. Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease. Nat. Rev. Nephrol. 2016; 12: 73-81. https://doi.org/10.1038/nrneph.2015.173Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Eknoyan G. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Annals of Internal Medicine . 2003; 139 (2): 137. https://doi.org/10.7326/0003-4819-139-2200307150-00013Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., Eknoyan G. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. Annals of Internal Medicine . 2003; 139 (2): 137. https://doi.org/10.7326/0003-4819-139-2200307150-00013Ma I., Guo M., Muruve D., Benediktsson H., Naugler C. Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study. BMC Nephrol. 2018; 19: 198. https://doi.org/10.1186/s12882-018-0991-5Ma I., Guo M., Muruve D., Benediktsson H., Naugler C. Sociodemographic associations with abnormal estimated glomerular filtration rate (eGFR) in a large Canadian city: a cross-sectional observation study. BMC Nephrol. 2018; 19: 198. https://doi.org/10.1186/s12882-018-0991-5Komenda P., Lavallee B., Ferguson T.W., Tangri N., Chartrand C., McLeod L., Gordon A., Dart A., Rigatto C. The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program. Am. J. Kidney Dis. 2016; 68 (4): 582-590. https://doi.org/10.1053/j.ajkd.2016.04.014Komenda P., Lavallee B., Ferguson T.W., Tangri N., Chartrand C., McLeod L., Gordon A., Dart A., Rigatto C. The Prevalence of CKD in Rural Canadian Indigenous Peoples: Results From the First Nations Community Based Screening to Improve Kidney Health and Prevent Dialysis (FINISHED) Screen, Triage, and Treat Program. Am. J. Kidney Dis. 2016; 68 (4): 582-590. https://doi.org/10.1053/j.ajkd.2016.04.014Philipneri M.D., Rocca Rey L.A., Schnitzler M.A., Abbott K.C., Brennan D.C., Takemoto S.K., Lentine K.L. (). Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clinical and Experimental Nephrology . 2008; 12 (1): 41-52. https://doi.org/10.1007/ s10157-007-0016-3Philipneri M.D., Rocca Rey L.A., Schnitzler M.A., Abbott K.C., Brennan D.C., Takemoto S.K., Lentine K.L. (). Delivery patterns of recommended chronic kidney disease care in clinical practice: administrative claims-based analysis and systematic literature review. Clinical and Experimental Nephrology . 2008; 12 (1): 41-52. https://doi.org/10.1007/s10157-007-0016-3Vassalotti J.A., Li S., McCullough P.A., Bakris G.L. Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin. Nephrol. 2010; 30 (1): 66-73. https://doi.org/10.1016/j.semnephrol.2009.10.004Vassalotti J.A., Li S., McCullough P.A., Bakris G.L. Kidney early evaluation program: a community-based screening approach to address disparities in chronic kidney disease. Semin. Nephrol. 2010; 30 (1): 66-73. https://doi.org/10.1016/j.semnephrol.2009.10.004

The authors declare that there are no conflicts of interest present.